Access to medicines Index
“Nobody realises that some people expend tremendous energy merely to be normal.” – Albert Camus
Education and experience:
MA in Human bioethics, 9 years experience working in global health and regulatory roles concerning the pharmaceutical sector.
Title PhD project:
Danny’s research focus is on the behaviour of companies in access to medicine, and understanding the incentives which shape this.
PhD Project description:
Team members and other people involved:
Prof. Dr. Bert Leufkens (promotor), Dr. Aukje Mantel-Teeuwisse, Jaysree K. Iyer. (co-promotors)
- Edwards DJ, Coppens D, Prasad T, Iyer JK (2015) Access to Hepatitis C treatment: A landscape of industry activity and policy recommendations. World Health Bulletin.
- Mugwagwa J, Edwards D, de Haan, S (2015) Assessing the implementation and influence of policies that support research and innovation systems for health: the cases of Mozambique, Senegal, and Tanzania. Health Research Policy and Systems.
- Røttingen JA, Regmi S, Eide M, Young A, Viergever RF, Årdal C, Guzman J, Edwards D, Matlin S and Terry RF (2013) Mapping available health R&D data: What’s there, what’s missing and what role for a Global Observatory. The Lancet.
- Edwards D & Ballantyne A (2009) Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors. Internal Medicine Journal.